You have read all your free articles, to continue reading subscribe to read the rest of this content.
Business development in a clinical stage vaccine company is constantly changing, intellectually challenging and meaningful job that pushes developments in society. Caspar Foghsgaard is Director of Business Development at the Norwegian vaccine platform company Vaccibody. The company mainly focusesAlready a subscriber Login You have read all your free articles, to…
Diamyd Medical has signed an agreement with Janssen Research & Development, the Juvenile Diabetes Research Foundation (JDRF) and the University of Alabama at Birmingham regarding the ongoing clinical trial “Effect of GABA or Combination GABA/GAD on the Progression of Type 1 Diabetes Mellitus iAlready a subscriber Login You have read…
Nordic Life Science asked Göran Forsberg, CEO of Cantargia, about Cantargia's future plans and his reactions to the Nobel Prizes. Congratulations on the listing on the main market Nasdaq Stockholm. What does this mean for the company? “Thank you! This means that the company will receive more exAlready a subscriber…
The paper “Gelatin- hydroxyapatite-calcium sulphate based biomaterial for long term sustained delivery of bone morphogenic protein-2 and zoledronic acid for increased bone formation: In-vitro and in-vivo carrier properties, - D Raina et al 2018 -shows that a novel macro-porous biomaterial, GelatinAlready a subscriber Login You have read all your free…
